Grifols
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Grifols and buy or sell other stocks, ETFs, and their options commission-free!About GRFS
Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others.
CEOJose Ignacio Abia Buenache
CEOJose Ignacio Abia Buenache
Employees25,258
Employees25,258
HeadquartersBarcelona, Catalonia
HeadquartersBarcelona, Catalonia
Founded1909
Founded1909
Employees25,258
Employees25,258
GRFS Key Statistics
Market cap6.50B
Market cap6.50B
Price-Earnings ratio11.46
Price-Earnings ratio11.46
Dividend yield1.76%
Dividend yield1.76%
Average volume599.51K
Average volume599.51K
High today$8.08
High today$8.08
Low today$7.97
Low today$7.97
Open price$8.00
Open price$8.00
Volume116.39K
Volume116.39K
52 Week high$11.14
52 Week high$11.14
52 Week low$7.09
52 Week low$7.09
GRFS News
TipRanks 4d
Grifols Lifts Q1 2026 Profit and Revenue as Immunoglobulins Surge and Debt is RefinancedUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
TipRanks 4d
Grifols reports Q1 adjusted EBITDA EUR 381M, up 0.8% ccReports Q1 total revenue EUR 1.7B, up 3.3% y/y cc. Group profit increased to EUR 73M in the first quarter, up 21.9% year-on-year. Nacho Abia, CEO of Grifols (GR...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.